Rediscovering Tocophersolan: A Renaissance for Nano-Based Drug Delivery and Nanotheranostic Applications

被引:3
|
作者
Wande, Dickson P. [1 ,2 ,3 ]
Cui, Qin [1 ,2 ]
Chen, Shijie [1 ,2 ]
Xu, Cheng [1 ,2 ]
Xiong, Hui [1 ,2 ]
Yao, Jing [1 ,2 ]
机构
[1] China Pharmaceut Univ, Dept Pharmaceut, State Key Lab Nat Med, 24 Tongjiaxiang, Nanjing 210009, Peoples R China
[2] China Pharmaceut Univ, Dept Pharmaceut, Jiangsu Key Lab Druggabil Biopharmaceut, 24 Tongjiaxiang, Nanjing 210009, Peoples R China
[3] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dept Pharmaceut, Dar Es Salaam, Tanzania
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Tocophersolan; bioavailability; bio-enhancer; drug delivery; nanoparticles; nanotheranostics; VITAMIN-E-TPGS; POLYETHYLENE-GLYCOL SUCCINATE; ENHANCED ORAL BIOAVAILABILITY; IN-VITRO CYTOTOXICITY; MIXED MICELLES; CO-DELIVERY; SOLUBILITY ENHANCEMENT; POLYMERIC MICELLES; TARGETED DELIVERY; PRODRUG MICELLES;
D O I
10.2174/1389450121666200611140425
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A unique and pleiotropic polymer, d-alpha-tocopheryl polyethylene glycol succinate (Tocophersolan), is a polymeric, synthetic version of vitamin E. Tocophersolan has attracted enormous attention as a versatile excipient in different biomedical applications including drug delivery systems and nutraceuticals. The multiple inherent properties of Tocophersolan allow it to play flexible roles in drug delivery system design, including excipients with outstanding biocompatibility, solubilizer with the ability to promote drug dissolution, drug permeation enhancer, P-glycoprotein inhibitor, and anticancer compound. For these reasons, Tocophersolan has been widely used for improving the bioavailability of numerous pharmaceutical active ingredients. Tocophersolan has been approved by stringent regulatory authorities (such as the US FDA, EMA, and PMDA) as a safe pharmaceutical excipient. In this review, the current advances in nano-based delivery systems consisting of Tocophersolan, with possibilities for futuristic applications in drug delivery, gene therapy, and nanotheranostics, were systematically curated.
引用
收藏
页码:856 / 869
页数:14
相关论文
共 50 条
  • [41] Nano-based anti-radiation drug
    Walter, Patrick
    CHEMISTRY & INDUSTRY, 2008, (03) : 9 - 9
  • [42] Recent Development and Future Aspects: Nano-Based Drug Delivery System in Cancer Therapy
    Rajendran, Sasireka
    Ravi, Sai Nandhini
    Nair, Vaishnavi M.
    Sree, R. Pooja
    Packirisamy, Azhagu Saravana Babu
    Palanivelu, Jeyanthi
    TOPICS IN CATALYSIS, 2024, 67 (1-4) : 203 - 217
  • [43] Naltrexone: A review of existing sustained drug delivery systems and emerging nano-based systems
    Goonoo, Nowsheen
    Bhaw-Luximon, Archana
    Ujoodha, Reetesh
    Jhugroo, Anil
    Hulse, Gary K.
    Jhurry, Dhanjay
    JOURNAL OF CONTROLLED RELEASE, 2014, 183 : 154 - 166
  • [44] Galactosylated block copolymers: a versatile nano-based tool for effective intracellular drug delivery?
    Canton, Irene
    Ustbas, Burcin
    Armes, Steven P.
    THERAPEUTIC DELIVERY, 2014, 5 (02) : 105 - 107
  • [45] Curcumin-encased hydroxyapatite nanoparticles as novel biomaterials for antimicrobial, antioxidant and anticancer applications: A perspective of nano-based drug delivery
    Sebastiammal, Saleth
    Fathima, Arul Sigamani Lesly
    Devanesan, Sandhanasamy
    AlSalhi, Mohamad S.
    Henry, Johnson
    Govindarajan, Marimuthu
    Vaseeharan, Baskaralingam
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 57
  • [46] Liposomal Nano-Based Drug Delivery Systems for Breast Cancer Therapy: Recent Advances and Progresses
    Yazdan, Mostafa
    Naghib, Seyed Morteza
    Mozafari, M. R.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2024, 24 (12) : 896 - 915
  • [47] Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems
    Wu, Kevin Y.
    Joly-Chevrier, Maxine
    Akbar, Dania
    Tran, Simon D.
    PHARMACEUTICS, 2023, 15 (04)
  • [48] Nano-Based Drug Delivery or Targeting to Eradicate Bacteria for Infection Mitigation: A Review of Recent Advances
    Yeh, Yuan-Chieh
    Huang, Tse-Hung
    Yang, Shih-Chun
    Chen, Chin-Chang
    Fang, Jia-You
    FRONTIERS IN CHEMISTRY, 2020, 8
  • [49] Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment
    Hanieh, Patrizia Nadia
    Consalvi, Sara
    Forte, Jacopo
    Cabiddu, Gianluigi
    De Logu, Alessandro
    Poce, Giovanna
    Rinaldi, Federica
    Biava, Mariangela
    Carafa, Maria
    Marianecci, Carlotta
    PHARMACEUTICS, 2022, 14 (03)
  • [50] Nano-based anti-tubercular drug delivery: an emerging paradigm for improved therapeutic intervention
    Bushra Nabi
    Saleha Rehman
    Sumit Aggarwal
    Sanjula Baboota
    Javed Ali
    Drug Delivery and Translational Research, 2020, 10 : 1111 - 1121